Underpinning SymBio’s corporate vision is the conduct of business activities in drug development founded on the principle of creating value for our stakeholders through Corporate Social Responsibility. We continue to contribute to society by addressing the high unmet medical needs of patients in Japan and other Asia Pacific countries as our corporate vision and goals are interwoven with those of patients and other major players in the pharmaceutical industry: investors, scientists, regulators and physicians.

It is our responsibility as a public company to enhance corporate value as we continue to conduct our business activities through close interactions with stakeholders, thereby enabling us to realize our corporate vision in drug development founded on the establishment of ‘symbiotic relationships’.

✖